Aramark Quarterly Liabilities and Equity in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Aramark quarterly Liabilities and Equity history and growth rate from Q3 2013 to Q3 2024.
  • Aramark Liabilities and Equity for the quarter ending September 27, 2024 was $12.7B, a 24.9% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $12.7B -$4.2B -24.9% Sep 27, 2024 10-K 2024-11-19
Q2 2024 $12.5B -$2.85B -18.5% Jun 28, 2024 10-Q 2024-08-06
Q1 2024 $12.6B -$2.9B -18.7% Mar 29, 2024 10-Q 2024-05-07
Q4 2023 $12.4B -$2.87B -18.8% Dec 29, 2023 10-Q 2024-02-06
Q3 2023 $16.9B +$1.79B +11.9% Sep 29, 2023 10-K 2024-11-19
Q2 2023 $15.4B +$409M +2.73% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $15.5B +$794M +5.41% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $15.3B +$825M +5.7% Dec 30, 2022 10-Q 2023-02-07
Q3 2022 $15.1B +$706M +4.91% Sep 30, 2022 10-K 2023-11-21
Q2 2022 $15B +$939M +6.68% Jul 1, 2022 10-Q 2022-08-09
Q1 2022 $14.7B +$175M +1.21% Apr 1, 2022 10-Q 2022-05-10
Q4 2021 $14.5B -$40.7M -0.28% Dec 31, 2021 10-Q 2022-02-08
Q3 2021 $14.4B -$1.34B -8.51% Oct 1, 2021 10-K 2022-11-22
Q2 2021 $14.1B -$1.57B -10.1% Jul 2, 2021 10-Q 2021-08-10
Q1 2021 $14.5B -$360M -2.42% Apr 2, 2021 10-Q 2021-05-11
Q4 2020 $14.5B +$233M +1.63% Jan 1, 2021 10-Q 2021-02-09
Q3 2020 $15.7B +$1.98B +14.4% Oct 2, 2020 10-K 2021-11-23
Q2 2020 $15.6B +$1.89B +13.8% Jun 26, 2020 10-Q 2020-08-04
Q1 2020 $14.8B +$1.14B +8.29% Mar 27, 2020 10-Q 2020-05-05
Q4 2019 $14.3B +$534M +3.89% Dec 27, 2019 10-Q 2020-02-04
Q3 2019 $13.7B +$16.2M +0.12% Sep 27, 2019 10-K 2020-11-24
Q2 2019 $13.7B +$64M +0.47% Jun 28, 2019 10-Q 2019-08-06
Q1 2019 $13.7B -$21.9M -0.16% Mar 29, 2019 10-Q 2019-05-07
Q4 2018 $13.7B +$1.21B +9.68% Dec 28, 2018 10-Q 2019-02-05
Q3 2018 $13.7B +$2.71B +24.7% Sep 28, 2018 10-K 2019-11-26
Q2 2018 $13.7B +$3.02B +28.3% Jun 29, 2018 10-Q 2018-08-07
Q1 2018 $13.7B +$3.24B +30.8% Mar 30, 2018 10-Q 2018-05-08
Q4 2017 $12.5B +$2.14B +20.6% Dec 29, 2017 10-Q 2018-02-06
Q3 2017 $11B +$424M +4.01% Sep 29, 2017 10-K 2018-11-21
Q2 2017 $10.7B +$319M +3.09% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $10.5B +$167M +1.62% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $10.4B +$234M +2.31% Dec 30, 2016 10-Q 2017-02-07
Q3 2016 $10.6B +$386M +3.78% Sep 30, 2016 10-K 2017-11-22
Q2 2016 $10.3B +$118M +1.16% Jul 1, 2016 10-Q 2016-08-10
Q1 2016 $10.3B +$47.2M +0.46% Apr 1, 2016 10-Q 2016-05-11
Q4 2015 $10.1B -$150M -1.46% Jan 1, 2016 10-Q 2016-02-10
Q3 2015 $10.2B -$259M -2.48% Oct 2, 2015 10-K 2016-11-23
Q2 2015 $10.2B -$61.6M -0.6% Jul 3, 2015 10-Q 2015-08-12
Q1 2015 $10.3B -$5.44M -0.05% Apr 3, 2015 10-Q 2015-05-13
Q4 2014 $10.3B +$50.4M +0.49% Jan 2, 2015 10-Q 2015-02-11
Q3 2014 $10.5B +$189M +1.84% Oct 3, 2014 10-K 2015-12-01
Q2 2014 $10.3B Jun 27, 2014 10-Q 2014-08-11
Q1 2014 $10.3B Mar 28, 2014 10-Q 2014-05-08
Q4 2013 $10.2B Dec 27, 2013 10-Q 2014-02-05
Q3 2013 $10.3B Sep 27, 2013 10-K 2014-12-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.